Loading data for MASS — first visit, this takes a few seconds.

알림

908 Devices Inc. (MASS)

NasdaqGM: MASS · 실시간 가격 · USD

10.08

-0.11 (-1.08%)

종가 기준: Aug 18, 2026, 3:59 PM

-1.08% (1D)

매수호가	n/a
시가총액	416.64M
매출 (ttm)	60.84M
순이익 (ttm)	-34.38M
베타	0.63
EPS (ttm)	-0.93
P/E (ttm)	n/a
선행 P/E	-33.6
P/B (ttm)	2.81
P/S (ttm)	6.85
Earnings Date	Nov 10, 2026

매도호가	n/a
거래량	351,229
평균 거래량 (20일)	347,100
시가	10.12
전일 종가	10.19
일중 범위	9.73 - 10.12
52주 범위	5.03 - 10.52
애널리스트	n/a
목표주가	n/a
배당	n/a
배당락일	n/a

MASS 소개

908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spectroscopy to identify, quantify, and track gases an...

[더 보기]

산업 Medical Devices

섹터 Healthcare

IPO 일자 Dec 18, 2020

직원 수 172

상장 거래소 NasdaqGM

티커 MASS

웹사이트 https://908devices.com

전체 기업 정보

재무 실적

2025년 908 Devices의 매출은 56.2M로, 전년 47.75M 대비 17.7% 증가했습니다. 순이익은 19.49M로, -126.99% 감소했습니다.

재무제표

어닝 서프라이즈

908 Devices가 Aug 11, 2026에 분기 실적을 발표했습니다:

매출 $13.38M 예상치 하회 $0, 및 13.62% 전년 대비 성장.

EPS -0.06 예상치 상회 0.08, 및 76.92% 전년 대비 성장.

다음 실적 발표

908 Devices Inc.의 실적 발표 예정일은 Nov 10, 2026, 장 시작 전입니다.
애널리스트 예상 매출은 ... 업그레이드

뉴스

18시간 전 · Motley Fool

908 Devices (MASS) Q2 2026 Earnings Call Transcript

Revenue grew 23% to $16.1 million as adjusted EBITDA loss improved 50%.

1일 전 · MarketBeat

TG Therapeutics Conference: 908 Devices Bets on Handheld Drug, Chemical Detection

908 Devices outlined its strategy to focus exclusively on handheld chemical and drug detection technologies for public safety and defense markets, following the divestiture of its life-sciences busine...

4일 전 · MarketBeat

908 Devices Eyes Growth in Handheld Drug and Chemical Detection Market

908 Devices (NASDAQ:MASS) is sharpening its focus on handheld chemical and drug detection systems for public safety, defense and law enforcement following the divestiture of its bioprocessing and biop...

6일 전 · GuruFocus.com

908 Devices Inc (MASS) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth and Raised ...

908 Devices Inc (MASS) delivered 23% revenue growth in Q2 2026, driven by robust demand and strategic acquisitions, while improving profitability and raising full-year guidance.

1주 전 · Moby

908 Devices Inc. Q2 2026 Earnings Call Summary

Moby summary of 908 Devices Inc.'s Q2 2026 earnings call

2 페이지 중 1

908 Devices Inc. (MASS)